Evidence map›Paper›PMID 32132234›Full record

ArticleJournal of virology2020

Characterization and Genomic Analysis of ValSw3-3, a New

Ling Chen, Quan Liu, Jiqiang Fan, Tingwei Yan, Haoran Zhang, Jinfang Yang, Deng Deng, Chaolan Liu, Ting Wei, Yingfei Ma

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Phage-antibiotic synergy attenuatesFrontiers in cellular and infection microbiology · 2026
    Article
  4. Article
  5. CRISPRi-mediated repression of threeJournal of bacteriology · 2025
    Article
  6. Article
  7. Article
  8. A NovelCurrent issues in molecular biology · 2024
    Article
  9. Isolation and Characterization of a Novel Phage againstInternational journal of molecular sciences · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Control ofAntibiotics (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Ling ChenShenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Quan LiuCollege of Life Science and Oceanography, Shenzhen University, Shenzhen, China.
Jiqiang FanShenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Tingwei YanCollege of Life Science and Technology, Jinan University, Guangzhou, China.
Haoran ZhangShenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Jinfang YangR&D Center, Shenzhen Alpha Feed Co., Ltd., Shenzhen, China.
Deng DengR&D Center, Shenzhen Alpha Feed Co., Ltd., Shenzhen, China.
Chaolan LiuAntibiotics Research and Reevaluation Key Laboratory of Sichuan Province, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu, China.
Ting WeiShenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China ting.wei@siat.ac.cn yingfei.ma@siat.ac.cn.
Yingfei MaShenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China ting.wei@siat.ac.cn yingfei.ma@siat.ac.cn.ORCID 0000-0002-2563-5390
BGI Group (China) · CNChinese Academy of Sciences · CNChengdu University · CNJinan University · CNShenzhen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel lytic bacteriophage, ValSw3-3, which efficiently infects pathogenic strains of

Indexed as

Genome, ViralGenomicsBase CompositionCapsid ProteinsDNA, ViralHost SpecificityMicroscopy, Electron, TransmissionPhylogenyProteomicsSewageSiphoviridaeVibrio alginolyticusWhole Genome SequencingCapsid ProteinsDNA, ViralSewagebacteriophagegenomic analysisSiphoviridaeVibrio alginolyticus

Identifiers

PMID32132234
PMCPMC7199398
OpenAlexW3008127222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.